Quanterix Corporation (NASDAQ: QTRX)'s merger with Akoya Biosciences, Inc. Upon completion of the proposed transaction, Quanterix shareholders will own approximately 70% of the combined company. If ...

UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00.

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Stryker (SYK) announced that it commenced, through a wholly owned subsidiary, Eagle 1 Merger Sub Inc., a cash tender offer to ...

PORTAGE, Mich. - Stryker Corporation (NYSE: NYSE:SYK), a global leader in medical technologies, has initiated a cash tender offer through its subsidiary, Eagle 1 Merger Sub, Inc., to acquire all ...

Stryker (SYK) announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, a cash tender offer to purchase all of ...

Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and outstanding shares of ...

Jim Cramer, the host of Mad Money, recently highlighted a surge in merger activity, pointing out that we’ve seen a ...

( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the ...

Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc., a company focused on treatments for central nervous system ...

Johnson & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter ...

JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments ...